<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>SE-0-SE-29-2015-03177_2-259-12182</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">New metal based drug candidates for the treatment of malaria and HIV</narrative>
   <narrative xml:lang="SV">Nya metallbaserade l&#xE4;kemedelskandidater f&#xF6;r behandling av malaria och HIV</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">Malaria och HIV/AIDS &#xE4;r mycket spridda sjukdomar som s&#xE4;rskilt drabbar utvecklingsl&#xE4;nder och d&#xE4;r orsakar samh&#xE4;lleliga  skador som f&#xF6;rsv&#xE5;rar l&#xE4;ndernas utveckling. Situationen &#xE4;r s&#xE4;rskilt allvarlig f&#xF6;r afrikanska l&#xE4;nder s&#xF6;der om Sahara. &#xC4;ven om mycketstora framsteg g&#xF6;rs i behandling och f&#xF6;rebyggande av dessa sjukdomar, finns det ett stort behov av kontinuerlig utveckling av nya l&#xE4;kemedel f&#xF6;r behandling. Detta &#xE4;r i synnerhet fallet f&#xF6;r malaria d&#xE4;rf&#xF6;r att malariaparasiter relativt snabbt utvecklar resistens mot l&#xE4;kemedel. I detta forskningsprojekt unders&#xF6;ks m&#xF6;jligheten att metallkomplex kan h&#xE4;mma  malaria eller HIV, med syftet att s&#xE5;dana metallkomplex skall kunna anv&#xE4;ndas som l&#xE4;kemedel. De metallkomplex som framst&#xE4;lls inneh&#xE5;ller k&#xE4;nda eller postulerade aktiva fragment fr&#xE5;n etablerade l&#xE4;kemedel. Forskningen &#xE4;r av preklinisk natur och syftar till att utveckla aktiva substanser som kan utg&#xF6;ra grund f&#xF6;r framtida l&#xE4;kemedelsutveckling.</narrative>
   <narrative xml:lang="EN">This project will focus on the preparation of metal complexes with (i) antimalarial properties or (ii) antiviral (anti-HIV) properties. The antimalarial properties will be tested on Plasmodium falciparum malaria parasites in collaboration with a research team at the University of Cape Town, South Africa. Similarly, the efficacy of the complexes as anti-HIV and antituberculosis agents will be assessed by in vitro cell line studies in collaboration with researchers at the Universities of Johannesburg and Pretoria, South Africa.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Lunds universitet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2016-01-01" type="2"></activity-date>
  <activity-date iso-date="2019-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="MZ" percentage="100">
   <narrative xml:lang="EN">Mozambique</narrative>
  </recipient-country>
  <sector code="121" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Health, General</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-28"></period-end>
   <value currency="USD" value-date="2016-01-01">42151.1914918483</value>
  </budget>
  <budget>
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-28"></period-end>
   <value currency="USD" value-date="2017-01-01">42198.0425880426</value>
  </budget>
  <budget>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">41501.7340973948</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-01-01"></transaction-date>
   <value currency="USD" value-date="2015-01-01">128361.7856761534</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-28"></transaction-date>
   <value currency="USD" value-date="2016-01-28">42151.1914918483</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-28"></transaction-date>
   <value currency="USD" value-date="2017-01-28">42198.0425880426</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-28"></transaction-date>
   <value currency="USD" value-date="2018-01-28">41501.7720703305</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <contribution contributionid="2015-03177_2" xmlns="http://sida.se/ns/contribution#"></contribution>
 </iati-activity>
</iati-activities>
